DNA Repair Company Announces New Clinical Findings Which May Help To Guide Breast Can
 

The DNA Repair Company (DNAR), an early-stage company focused on personalized approaches to cancer treatment, announced today that it has identified a promising set of protein biomarkers that may aid in the treatment of a particularly aggressive form of breast cancer. These findings were presented today at the CTRC-AACR San Antonio Breast Cancer Symposium.

More...